This is an infographic created by Symmation to support the concept that embryonic stem (ES) cells hold significant potential for deriving differentiated cell types, including insulin-producing beta cells. Knowledge of genes and signals controlling pancreatic development in the whole animal can enable test tube recapitulation of specific embryonic programs in stem or progenitor cells to produce functioning insulin-producing cells for replacement therapy in type 1 diabetes.
This media piece was utilized in a top-level strategic report written by the NIH’s NIDDK division, for the US Congress as well as the public at large.
